Dr. Brian H. Buck, MD, FRCPC
Claim this profileUniversity of Alberta
Studies Stroke
Studies Bleeding
9 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Brian H. Buck, MD, FRCPC is currently running
Edoxaban
for Atrial Fibrillation
This trial is testing if edoxaban, a daily blood-thinning medication, can safely reduce stroke risk in high-risk atrial fibrillation patients who have had previous brain bleeds. The goal is to see if it works better than not using any blood thinners or using simpler treatments. Edoxaban has been shown to be effective in preventing stroke with a lower risk of bleeding.
Recruiting3 awards Phase 4
Guided Stepping Training
for Stroke Recovery
Goal of research program: To understand person-specific factors, such as imaging markers and activity patterns early after stroke, that may guide precision rehabilitation to optimize function and improve recovery. Objectives: 1. Test the effect of reducing sedentary behaviour early after stroke on functional mobility and global disability outcomes. 2. Determine the impact of neuroimaging biomarkers (e.g. leukoaraiosis) on response to rehabilitation. 3. Explore the predictive value of accelerometry as an adjunct to the subjective modified Rankin Scale (mRS) to assess functional disability after stroke. Experimental approach/Research Plan/Use of Funds: The investigators aim to recruit 50 participants within 1 week of ischemic stroke onset, aged ≥ 18 years, medically stable as deemed by their physicians, able to walk at least 5 meters with/without gait aid and with ongoing walking or balance goals. Demographic and stroke characteristics, including stroke risk factors, infarct location and volume, leukoaraiosis on routine MRI, and acute stroke treatments (e.g., thrombectomy) will be determined and documented. A battery of impairment, psychosocial, and functional measures, including the mRS and Timed-Up and Go test (primary outcomes) will be completed. Subsequently, participants will be set up to wear activPAL accelerometer, validated in stroke, for 1 week. Following randomization, a sedentary behaviour change intervention will span 6 weeks, with final follow-up assessments at 90 days.
Recruiting1 award N/A5 criteria
More about Brian H. Buck, MD, FRCPC
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Brian H. Buck, MD, FRCPC has experience with
- Tenecteplase
- Edoxaban 30 Mg
- Edoxaban 60 MG
- Alteplase
- Recombinant Activated Factor VII (rFVIIa)
- Placebo
Breakdown of trials Brian H. Buck, MD, FRCPC has run
Stroke
Bleeding
Atrial Fibrillation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian H. Buck, MD, FRCPC specialize in?
Brian H. Buck, MD, FRCPC focuses on Stroke and Bleeding. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Brian H. Buck, MD, FRCPC currently recruiting for clinical trials?
Yes, Brian H. Buck, MD, FRCPC is currently recruiting for 5 clinical trials in Edmonton Alberta. If you're interested in participating, you should apply.
Are there any treatments that Brian H. Buck, MD, FRCPC has studied deeply?
Yes, Brian H. Buck, MD, FRCPC has studied treatments such as Tenecteplase, Edoxaban 30 mg, Edoxaban 60 MG.
What is the best way to schedule an appointment with Brian H. Buck, MD, FRCPC?
Apply for one of the trials that Brian H. Buck, MD, FRCPC is conducting.
What is the office address of Brian H. Buck, MD, FRCPC?
The office of Brian H. Buck, MD, FRCPC is located at: University of Alberta, Edmonton, Alberta T6G2B7 Canada. This is the address for their practice at the University of Alberta.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.